Literature DB >> 11921055

Subjective memory complaints: objective neural markers in patients with Alzheimer's disease and major depressive disorder.

Georg Grön1, Daniel Bittner, Bernd Schmitz, Arthur P Wunderlich, Matthias W Riepe.   

Abstract

Patients with probable Alzheimer's disease and depressive patients frequently present with subjective memory complaints. Objective distinction of underlying neuronal substrate malfunction and early cross-sectional differential diagnosis have been elusive thus far. We used repetitive learning and free recall of abstract geometric patterns during functional magnetic resonance imaging to assess episodic memory in older subjects (ages 56-64 years) who sought first-time medical attention with subjective memory complaints and were diagnosed with probable Alzheimer's disease (NINCDS-ADRDA criteria; ages 51-67 years) or major depressive disorder (DSM-IV; ages 50-65 years). Contrasting healthy seniors or depressive patients with Alzheimer's disease patients revealed superiority of hippocampal activation. Contrasting Alzheimer's disease patients with seniors showed bilateral prefrontal activity as a correlate of futile compensation of episodic memory failure. Contrasting patients who had major depressive disorder with seniors or patients who had Alzheimer's disease showed bilateral activation of the orbitofrontal cortex and the anterior cingulate. Subjective memory complaints may be classified objectively and very early with functional magnetic resonance imaging of episodic memory in groups of patients with Alzheimer's disease and depressive syndrome. This may facilitate drug trials with evaluation of specific treatments, but further studies will be needed to establish the differential diagnosis for the individual patient.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11921055     DOI: 10.1002/ana.10157

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  30 in total

Review 1.  MRI studies in late-life mood disorders.

Authors:  Carmen Andreescu; Howard Aizenstein
Journal:  Curr Top Behav Neurosci       Date:  2012

Review 2.  Neuroimaging in psychiatric disorders.

Authors:  Joseph C Masdeu
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

Review 3.  Potential of functional MRI as a biomarker in early Alzheimer's disease.

Authors:  Reisa Sperling
Journal:  Neurobiol Aging       Date:  2011-12       Impact factor: 4.673

4.  Medial temporal lobe function and structure in mild cognitive impairment.

Authors:  Bradford C Dickerson; David H Salat; Julianna F Bates; Monika Atiya; Ronald J Killiany; Douglas N Greve; Anders M Dale; Chantal E Stern; Deborah Blacker; Marilyn S Albert; Reisa A Sperling
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

5.  Altered resting state networks in mild cognitive impairment and mild Alzheimer's disease: an fMRI study.

Authors:  Serge A R B Rombouts; Frederik Barkhof; Rutger Goekoop; Cornelis J Stam; Philip Scheltens
Journal:  Hum Brain Mapp       Date:  2005-12       Impact factor: 5.038

6.  Gender-specificities in Alzheimer's disease and mild cognitive impairment.

Authors:  U Beinhoff; H Tumani; J Brettschneider; D Bittner; M W Riepe
Journal:  J Neurol       Date:  2008-01-18       Impact factor: 4.849

7.  Applying new research criteria for diagnosis of early Alzheimer's disease: sex and intelligence matter.

Authors:  U Beinhoff; H Tumani; M W Riepe
Journal:  Int J Alzheimers Dis       Date:  2009-08-12

Review 8.  A new integrative model of cerebral activation, deactivation and default mode function in Alzheimer's disease.

Authors:  Marc Wermke; Christian Sorg; Afra M Wohlschläger; Alexander Drzezga
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-03       Impact factor: 9.236

Review 9.  Advances in functional magnetic resonance imaging: technology and clinical applications.

Authors:  Bradford C Dickerson
Journal:  Neurotherapeutics       Date:  2007-07       Impact factor: 7.620

10.  Quality of life as an outcome in Alzheimer's disease and other dementias--obstacles and goals.

Authors:  Matthias W Riepe; Thomas Mittendorf; Hans Förstl; Lutz Frölich; Martin Haupt; Reiner Leidl; Christoph Vauth; Matthias Graf von der Schulenburg
Journal:  BMC Neurol       Date:  2009-08-25       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.